Hybrid Conferencee

International Conference on Cancer Biology and Targeted Therapies (ICCBTT - 26)

8th - 9th September 2026 | Athens, Greece

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Athens. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Athens event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Athens conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Athens, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Athens."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Cancer Genomics

This track focuses on the latest developments in cancer genomics, including the identification of oncogenes and tumor suppressor genes. Participants will explore how genomic data can inform targeted therapies and precision medicine approaches.

Track 02

Molecular Mechanisms of Tumorigenesis

This session will delve into the molecular pathways that drive cancer development, including signaling pathways and their roles in cell proliferation and apoptosis. Understanding these mechanisms is crucial for developing effective therapeutic strategies.

Track 03

Tumor Microenvironment and Cancer Progression

This track examines the interactions between tumor cells and their microenvironment, highlighting how these relationships influence cancer progression and metastasis. Insights gained here are vital for designing novel therapeutic interventions.

Track 04

Cancer Biomarkers and Diagnostics

This session will explore the discovery and validation of cancer biomarkers that can aid in early diagnosis and treatment monitoring. The focus will be on how these biomarkers can enhance personalized oncology.

Track 05

Innovations in Targeted Therapies

This track will highlight recent innovations in targeted therapies, including the development of new drugs that specifically target molecular pathways involved in cancer. Discussions will include case studies and clinical trial outcomes.

Track 06

Mechanisms of Drug Resistance in Cancer

This session will investigate the various mechanisms by which cancer cells develop resistance to chemotherapeutics. Understanding these mechanisms is essential for improving treatment efficacy and patient outcomes.

Track 07

Precision Medicine in Oncology

This track focuses on the implementation of precision medicine in oncology, emphasizing individualized treatment plans based on genetic, environmental, and lifestyle factors. Participants will discuss challenges and successes in tailoring therapies to specific patient profiles.

Track 08

Emerging Therapeutic Strategies in Cancer Treatment

This session will cover emerging therapeutic strategies, including immunotherapy and combination therapies, that aim to enhance treatment effectiveness. The discussions will focus on innovative approaches to overcome current limitations in cancer care.

Track 09

Cellular Mechanisms of Metastasis

This track will explore the cellular and molecular mechanisms underlying cancer metastasis, including the role of the tumor microenvironment. Understanding these processes is critical for developing strategies to prevent and treat metastatic disease.

Track 10

Oncogenes and Tumor Suppressors: Current Insights

This session will provide an overview of the latest research on oncogenes and tumor suppressor genes, focusing on their roles in cancer biology. Participants will discuss how these insights can inform targeted therapeutic approaches.

Track 11

Future Directions in Cancer Research

This track will look ahead to future directions in cancer research, including novel technologies and methodologies that could revolutionize our understanding of cancer biology. Emphasis will be placed on interdisciplinary approaches and collaborative efforts in the field.